P. Nathan

Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised phase 3 trial

B. Escudier, S. Oosting, S. Bracarda, 2020 .

Breast cancer, early stage

M. Espié, C. Mermel, R. Gelber, 2012 .